Nicotine Replacement Therapy Sampling for Smokers in the Community
QTW2023
Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2023: a Randomised Controlled Trial of 1-week Nicotine Replacement Therapy Sampling
1 other identifier
interventional
1,014
1 country
1
Brief Summary
The aim of this clinical trial is to test the effectiveness of 1-week nicotine replacement therapy sampling delivered by lay counsellors in promoting smoking cessation in smokers in the community.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 31, 2023
CompletedStudy Start
First participant enrolled
June 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJuly 11, 2023
July 1, 2023
12 months
May 19, 2023
July 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemically validated tobacco abstinence
Verified by a negative salivary cotinine test
6 months
Secondary Outcomes (9)
Biochemically validated tobacco abstinence
3 months
Self-reported 7-day point-prevalence tobacco abstinence
3 months
Self-reported 7-day point-prevalence tobacco abstinence
6 months
Self-reported 24-hour quit attempt
3 months
Self-reported 24-hour quit attempt
6 months
- +4 more secondary outcomes
Other Outcomes (4)
Self-reported reduction of tobacco consumption
3 months
Self-reported reduction of tobacco consumption
6 months
Change in motivation to quit from baseline through 3-month follow-up
3 months
- +1 more other outcomes
Study Arms (2)
Intervention group
EXPERIMENTAL1-week nicotine replacement therapy sample + Brief cessation advice
Control group
ACTIVE COMPARATORBrief cessation advice
Interventions
Participants will be given an 1-week sample of nicotine replacement therapy (patch or gum) with brief instructions on how to use the product
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model: A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Eligibility Criteria
You may qualify if:
- Hong Kong residents aged 18 years or above
- Smoke cigarette or heated tobacco product or e-cigarette daily in the past 3 months
- Exhaled carbon monoxide level ≥4 part per million or a positive salivary cotinine test
- Able to communicate in and read Chinese
- Have a local contact number
You may not qualify if:
- Participating in another smoking cessation programme or using any smoking cessation drug or nicotine replacement therapy
- Pregnant or breastfeeding
- Recent (≤ 2 weeks) angina, cardiac arrhythmia or heart attacks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Community sites
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tzu Tsun Luk, PhD, RN
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
May 19, 2023
First Posted
May 31, 2023
Study Start
June 17, 2023
Primary Completion
May 31, 2024
Study Completion
June 30, 2024
Last Updated
July 11, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share